Aytu BioScience Inc

NASDAQ AYTU

Data sourced from iex and EODHD
Download Data

Aytu BioScience Inc Income Statement 2006 - 2024

This table shows the Income Statement for Aytu BioScience Inc going from 2006 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-03-31
Revenue
M 18 23 31 31 23 26 28 27 24 23 22 23 13 15 15 15 8 3 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 - - - - - - - 0 - - 0 0 0 - - - - - - - - - - -
Cost of Revenue
M 6 7 12 12 10 9 10 13 12 11 9 12 14 6 5 5 2 1 0 1 1 1 0 0 1 0 0 0 0 1 0 0 0 0 0 0 2 2 2 6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M 12 16 19 19 13 17 18 15 13 12 12 11 0 9 10 10 6 3 1 1 2 1 1 1 -1 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 - - - - - - - 0 - - 0 0 0 - - - - - - - - - - -
Operating Expenses
M 14 14 18 16 22 21 20 12 -21 24 40 35 25 15 17 17 11 8 6 6 6 6 4 5 7 5 5 2 5 4 6 14 4 3 3 2 0 0 0 0 0 - 0 0 0 - 0 0 - - - - - - - 0 - - 0 0 0 - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 5 5 6 14 7 8 7 7 8 8 8 9 13 13 11 14 10 7 5 5 5 5 4 4 5 5 5 4 4 4 6 3 2 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0
Research and Development (R&D) Expenses
M 1 1 0 0 1 2 1 4 4 5 2 5 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 1 1 1 1 1 1 1 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M 8 8 12 1 14 12 11 1 -33 11 30 22 12 2 4 2 1 1 1 1 1 1 1 0 2 0 0 -2 0 0 0 8 0 0 0 0 -2 -1 -1 -4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 6 6 4 16 12 13 10 9 11 13 11 15 5 9 12 12 9 7 5 5 5 5 4 4 4 4 5 0 5 4 6 6 3 3 3 2 0 -2 -2 -6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -2 2 0 3 -9 -4 -2 3 34 -11 -28 -24 -26 -6 -7 -6 -5 -5 -5 -5 -4 -5 -3 -4 -8 -4 -4 -1 -5 -4 -6 -13 -3 -3 -2 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense
M - - 2 - -1 3 1 20 87 1 39 15 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 -
Non-operating Income/Expense
M 0 -2 -5 -5 2 -3 -1 -20 -87 0 -20 -3 -6 -4 3 3 -1 5 0 -10 0 0 0 5 3 1 0 -1 0 0 1 -8 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 - 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 - 0 0 0
EBT
M -3 1 -2 -2 -7 -7 -3 -18 -53 -12 -28 -19 -25 -10 -3 -3 -5 0 -5 -15 -4 -5 -3 1 -3 -4 -4 -3 -5 -5 -6 -15 -7 -3 -2 -2 -2 0 0 0 0 0 0 0 0 0 0 - 0 - 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 - 0 0 0
Income Tax Provision
M 0 1 4 - -1 4 1 20 87 0 0 0 12 8 -8 - 1 -10 0 20 0 0 0 0 -1 -1 0 1 0 0 -1 8 0 0 0 0 2 0 0 0 0 0 0 - 0 0 0 - 0 - 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 - 0 0 0
Income after Tax
M -2 0 -6 - -6 -10 -4 -38 -140 -12 -28 -19 -37 -17 5 - -6 10 -5 -34 -5 -5 -3 1 -2 -3 -4 -4 -5 -5 -5 -24 -7 -3 -2 -2 -4 0 0 0 0 0 0 - 0 0 0 - 0 - 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 - 0 0 0
Non-Controlling Interest
M - - 0 0 -5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - 0 - - - - - - - - - - - - - - - - - - - - -
Net Income
M - - -8 -2 -2 -7 -3 -18 -53 -12 -28 -19 -25 -10 -4 -3 -5 0 -5 -15 -4 -5 -3 1 -3 -4 -4 -17 -5 -5 -6 -28 -7 -3 -2 -6 -2 0 0 0 0 0 0 0 - - - - - - 0 - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 5,533,555.00 5,517,670.00 4,144,097.00 5,517,174.00 3,726,779.00 3,110,304.00 2,525,654.00 1,797,745.00 1,484,492.00 1,320,623.00 1,279,866.00 1,175,994.00 904,623.00 664,095.00 566,771.00 12,583,735.00 176,377.00 87,691.00 76,630.00 69,104.00 45,305.00 32,385.00 8,799.00 3,519,640.00 2,963.00 1,028.00 1,056.00 206.00 172.00 135.00 63.00 46.00 23.00 14.00 14.00 5,940.00 1.00 9.00 180.00 9.00 223,262.00 8.00 160.00 8.00 8.00 8.00 160.00 8.00 8.00 160.00 160.00 7.00 7.00 6.00 120.00 6.00 5.00 5.00 100.00 5.00 5.00 5.00 100.00 5.00 5.00 1.00 100.00 1.00 100.00 1.00 1.00 1.00
EBITDA
M -2 2 8 - -9 -1 1 4 37 -8 14 -11 -7 0 -9 -4 -3 -9 -4 6 -4 -4 -3 1 -3 -3 -4 0 -4 -3 -5 -5 -3 -3 -2 -2 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 2 2 1 - 0 3 2 1 3 3 3 1 6 2 2 2 2 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 0 0 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 -
EBIT
M -4 0 7 3 -9 -4 -2 3 34 -11 11 -13 -14 -2 -11 -6 -5 -10 -5 5 -4 -5 -3 1 -4 -4 -4 0 -5 -4 -6 -6 -3 -3 -2 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 9.27 136.18 -163.37 - 18.86 -55.24 -47.07 -115.00 -164.26 0.03 0.38 -1.38 -46.63 -78.96 254.80 - -10.11 4,645.41 -3.89 -136.02 -4.43 -1.84 1.37 -4.78 45.57 14.11 7.06 -41.62 -5.29 -4.78 11.49 -55.13 0.38 -2.35 -4.97 -0.19 -99.46 444.33 -3.62 -5.85 -7.38 -9.92 -13.89 - -9.57 -8.11 -1.37 - -8.48 - -0.59 -3.35 -1.95 -2.95 -1.95 -11.36 -7.96 0.57 -1.39 -8.02 -4.81 - -1.21 -3.16 -4.63 -6.87 -23.91 -100.00 - -3.42 -6.70 -100.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 -2 0 0 0 0 0 0 0 - - - - - - 0 - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% 64.99 70.65 60.41 60.41 56.06 65.81 65.20 54.07 52.42 53.18 56.88 48.12 -1.48 60.40 69.23 69.23 75.50 80.91 73.91 62.16 74.06 70.74 71.30 73.94 -87.29 63.33 73.31 58.16 63.71 30.57 72.50 64.27 49.02 48.00 92.34 100.00 100.00 100.00 0.00 100.00 100.00 - 100.00 42.86 100.00 - 100.00 100.00 - - - - - - - 100.00 - - 100.00 100.00 100.00 - - - - - - - - - - -
Operating Income Margin
% -13.69 10.31 0.55 9.14 -40.87 -15.96 -5.51 9.86 140.93 -48.84 -126.50 -102.51 -190.37 -36.81 -44.64 -43.33 -58.77 -156.43 -328.89 -266.96 -180.78 -253.52 -238.64 -413.58 -1,239.64 -380.01 -404.84 -166.27 -543.60 -528.80 -854.80 -1,418.96 -482.83 -642.06 -443.81 -1,181.83 -39.45 -64.17 -39.97 -1,113.20 -2,055.90 - 259.23 -683.31 -717.20 - -981.20 -981.20 - - - - - - - -789.60 - - 595.14 -501.03 -864.57 - - - - - - - - - - -
Net Income Margin
% - - -26.42 -7.99 -10.81 -25.47 -10.42 -64.49 -219.32 -49.94 -127.19 -80.90 -188.84 -62.89 -28.98 -21.16 -65.38 -6.75 -342.34 -847.05 -189.08 -259.48 -240.68 59.20 -464.20 -349.45 -394.52 -2,068.69 -583.48 -606.70 -820.11 -3,006.50 -1,088.23 -709.88 -467.02 -3,216.72 -7,730.87 -41.44 -58.35 0.00 -1,182.40 - 471.63 -388.06 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -13.69 10.31 26.09 - -40.43 -3.12 2.90 12.97 151.89 -36.07 64.41 -48.57 -54.14 -0.55 -58.50 -26.74 -38.87 -290.17 -268.64 349.01 -149.43 -224.92 -199.75 142.11 -536.19 -317.05 -344.12 32.66 -483.09 -415.35 -737.01 -578.24 -454.25 -617.88 -417.36 -1,157.41 -7,579.58 -59.15 -35.54 -993.60 -1,936.40 - 225.11 -613.94 -645.89 - -903.31 -903.31 - - - - - - - -650.40 - - 476.86 -382.63 -712.69 - - - - - - - - - - -
EBIT Ratio
% -23.70 0.81 22.20 9.14 -40.87 -15.96 -5.51 9.86 140.93 -47.64 52.18 -53.91 -100.78 -13.23 -75.09 -43.33 -58.77 -320.19 -329.02 305.13 -180.70 -254.67 -238.64 75.53 -644.98 -380.01 -404.84 -14.92 -543.60 -528.80 -854.80 -618.79 -482.83 -642.06 -443.81 -1,181.83 -39.45 -64.17 -39.97 -1,113.20 -2,055.90 - 259.23 -683.31 -717.20 - -981.20 -981.20 - - - - - - - -789.60 - - 595.14 -501.03 -864.57 - - - - - - - - - - -
EBT Ratio
% -14.68 2.65 -7.99 -7.99 -31.67 -25.47 -10.42 -64.49 -219.32 -49.95 -127.68 -79.80 -188.84 -62.89 -21.16 -21.16 -65.38 -6.75 -342.34 -847.08 -189.10 -259.48 -240.68 59.20 -464.20 -349.45 -394.52 -363.68 -583.48 -606.70 -820.11 -1,632.07 -1,088.23 -709.88 -467.02 -1,184.08 -7,730.87 -66.11 -41.47 -1,182.40 -2,219.60 - 301.03 -758.00 -780.51 - -3,410.00 - - - - - - - - -544.74 - - 3,365.37 -544.74 -908.29 - - - - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email